Shefferman Jesse 4

What Happened
Jesse Shefferman, CEO, President and Director of Protara Therapeutics (TARA), had 16,322 shares withheld (disposed) to satisfy income tax obligations related to vested Restricted Stock Units (RSUs). The withholding was reported as a disposition at $5.60 per share, totaling $91,403, with the transaction dated January 20, 2026 and the Form 4 filed January 22, 2026.

Key Details

• Transaction type: Tax withholding to satisfy income tax on RSU vesting (Form 4 code F; footnote F1).
• Date of transaction: 2026-01-20; Filing date: 2026-01-22 (appears timely).
• Shares withheld/disposed: 16,322 shares at $5.60 per share; total value $91,403.
• Footnote: F1 states shares were withheld to satisfy income tax obligations associated with RSU awards granted Jan 19, 2023 and Jan 19, 2024.
• Shares owned after transaction: Not specified in this filing.

Context
This was a tax-withholding disposition tied to RSU vesting (a routine administrative event), not an open-market sale or purchase that necessarily signals trading intent. Tax withholdings are common when RSUs vest and do not, by themselves, indicate the insider’s view of the company’s prospects.